November 29 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said on Monday that its consolidated net profit rose to 50.5 million levs ($29.2 million/25.8 million euro) in the first nine months of 2021 from 21.9 million levs in the same period of last year.